Swiss All Share Index

Swiss All Share Index handeln
17.970,97 PKT -10,34 PKT -0,06 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
22.10.19 Novartis Underweight Morgan Stanley
22.10.19 Novartis Underweight JP Morgan Chase & Co.
22.10.19 UBS overweight JP Morgan Chase & Co.
22.10.19 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
22.10.19 ams-OSRAM Neutral JP Morgan Chase & Co.
22.10.19 Novartis Neutral UBS AG
22.10.19 Novartis Conviction Buy List Goldman Sachs Group Inc.
22.10.19 UBS Neutral Goldman Sachs Group Inc.
22.10.19 Novartis Hold Deutsche Bank AG
21.10.19 Roche buy Goldman Sachs Group Inc.
21.10.19 Novartis Underweight Morgan Stanley
21.10.19 Nestlé buy Jefferies & Company Inc.
21.10.19 Swiss Re Outperform Credit Suisse Group
21.10.19 ams-OSRAM Neutral JP Morgan Chase & Co.
21.10.19 Nestlé Hold HSBC
21.10.19 Roche overweight JP Morgan Chase & Co.
18.10.19 Novartis Underweight JP Morgan Chase & Co.
18.10.19 Nestlé Hold HSBC
18.10.19 Swiss Re Outperform Credit Suisse Group
18.10.19 Nestlé buy Baader Bank
18.10.19 UBS Outperform Credit Suisse Group
18.10.19 Nestlé buy UBS AG
18.10.19 Novartis Neutral UBS AG
18.10.19 Holcim overweight JP Morgan Chase & Co.
17.10.19 Roche overweight Morgan Stanley
17.10.19 UBS Neutral JP Morgan Chase & Co.
17.10.19 Roche Neutral Credit Suisse Group
17.10.19 Nestlé buy Jefferies & Company Inc.
17.10.19 Nestlé Underperform RBC Capital Markets
17.10.19 Nestlé market-perform Bernstein Research
17.10.19 Roche buy Deutsche Bank AG
17.10.19 Nestlé overweight Morgan Stanley
17.10.19 Roche overweight Barclays Capital
17.10.19 Nestlé buy Goldman Sachs Group Inc.
17.10.19 Givaudan Neutral JP Morgan Chase & Co.
17.10.19 Novartis Underweight JP Morgan Chase & Co.
17.10.19 Nestlé overweight JP Morgan Chase & Co.
17.10.19 Roche overweight JP Morgan Chase & Co.
17.10.19 Roche buy Goldman Sachs Group Inc.
16.10.19 Roche overweight Morgan Stanley